Park Avenue Securities’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
4,643
-1,591
-26% -$105K ﹤0.01% 1531
2026
Q1
$444K Buy
6,234
+518
+9% +$40.8K ﹤0.01% 1162
2025
Q4
$469K Buy
5,716
+1,184
+26% +$92.3K ﹤0.01% 1120
2025
Q3
$340K Buy
+4,532
New +$338K ﹤0.01% 1365
2025
Q2
Sell
-5,887
Closed -$475K 1518
2025
Q1
$475K Buy
5,887
+1,437
+32% +$123K 0.01% 872
2024
Q4
$348K Buy
4,450
+392
+10% +$33.3K ﹤0.01% 1218
2024
Q3
$381K Buy
4,058
+1,135
+39% +$95.3K ﹤0.01% 1086
2024
Q2
$228K Buy
2,923
+429
+17% +$35K ﹤0.01% 1271
2024
Q1
$227K Buy
+2,494
New +$208K ﹤0.01% 1278

Other funds holding GEHC

Park Avenue Securities's GEHC Position: Q2 2026 in Review

Park Avenue Securities reduced its GE HealthCare (GEHC) stake by 26% in Q2 2026, selling an estimated $105K and leaving 4,643 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Park Avenue Securities first reported a position in GEHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $475K in Q1 2025. 451 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Park Avenue Securities held 4,643 shares of GE HealthCare worth $297K as of Q2 2026.
  • Park Avenue Securities sold 1,591 GE HealthCare shares in Q2 2026, an estimated $105K.
  • GE HealthCare made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1531 holding.
  • Park Avenue Securities first reported a position in GE HealthCare in Q1 2024 and has held it in 9 quarters since.
  • Park Avenue Securities's GE HealthCare position peaked at $475K in Q1 2025.
  • 451 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.